Exothera has announced the appointment of Cedric Volanti as its new Chief Executive Officer. Volanti, with extensive expertise in biotech, is set to lead the company into a new phase of growth. The announcement was made on July 18, 2024, with
Exothera, a provider of nucleic acids and viral vector development and manufacturing services, has launched a new nucleic acids service offering. This service is powered by a continuous-batch RNA production platform, Ntensify. Developed by Exothera’s sister company, Quantoom Biosciences, the
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
